Vera Therapeutics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
BRISBANE, Calif., Dec. 27, 2023 (GLOBE NEWSWIRE) — Vera Therapeutics, Inc. (Nasdaq: VERA), a late clinical-stage biotechnology company focused on […]
Turbo Energy Announces Interim Results for the Period Ended June 30, 2023
Valencia, Spain, Dec. 27, 2023 (GLOBE NEWSWIRE) — Turbo Energy, S.A. (NASDAQ: TURB), the leading energy-saving technology company, leveraging artificial […]
WiMi Built an Efficient, Blockchain-compatible Heterogeneous Computing Framework
Beijing, Dec. 27, 2023 (GLOBE NEWSWIRE) — WiMi Hologram Cloud Inc. (NASDAQ: WIMI) (“WiMi” or the “Company”), a leading global […]
Zevra Therapeutics Announces Resubmission of Arimoclomol New Drug Application to the U.S. Food and Drug Administration
CELEBRATION, Fla., Dec. 27, 2023 (GLOBE NEWSWIRE) — Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) a rare disease therapeutics company, today announced […]
Wearable Devices Ramps Up Inventory in Anticipation of its Participation at the 2024 CES Showcase
YOKNEAM ILLIT, ISRAEL, Dec. 27, 2023 (GLOBE NEWSWIRE) — Wearable Devices Ltd. (the “Company” or “Wearable Devices”) (Nasdaq: WLDS, WLDSW), […]
Iovance Biotherapeutics Announces Clinical Program Update for LN-145 in Non-Small Cell Lung Cancer
SAN CARLOS, Calif., Dec. 27, 2023 (GLOBE NEWSWIRE) — Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, […]
Broadwind Announces Agreement to Sell Approximately $15 Million of IRA Advanced Manufacturing Tax Credits
CICERO, Ill., Dec. 27, 2023 (GLOBE NEWSWIRE) — Broadwind (Nasdaq: BWEN), a diversified precision manufacturer of specialized components and solutions […]
Plug Power Completes First Installation of Electrolyzer at Amazon Fulfillment Center
LATHAM, N.Y., Dec. 27, 2023 (GLOBE NEWSWIRE) — Plug Power Inc. (NASDAQ: PLUG), a global leader in comprehensive hydrogen solutions […]
Synlogic Announces Contract with the Air Force Research Lab
CAMBRIDGE, Mass., Dec. 27, 2023 (GLOBE NEWSWIRE) — Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage biotechnology company advancing novel, oral, non-systemically […]
Avalo Therapeutics Announces 1-for-240 Reverse Stock Split
WAYNE, Pa. and ROCKVILLE, Md., Dec. 27, 2023 (GLOBE NEWSWIRE) — Avalo Therapeutics, Inc. (Nasdaq: AVTX) today announced a 1-for-240 […]
